ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 167

Lipidomic Profiles of Synovial Fluid from Patients with Oligoarticular Juvenile Idiopathic Arthritis Naïve to Treatment

Melissa Elder 1, Luciana Paim marques2, Akaluck Thatayatikom 1, John Bowden 2, Bianca da SIlva 2 and Juan Aristizabal 2, 1University of Florida, Gainesville, 2University of Florida, Gainesville, Florida

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: Antiphospholipid, juvenile idiopathic arthritis (JIA)

  • Tweet
  • Email
  • Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Saturday, May 2, 2020

Title: Poster Session 3

Session Type: ACR Abstract Session

Session Time: 4:15PM-5:15PM

Background/Purpose: Metabolomic and lipidomic pathways serve as key sensors and effectors of genetic, epigenetic, and environmental factors that shape the development and function of the immune system. Current research in humans and animal models is using these techniques to characterize patterns that may predispose to subtypes of disease and response to treatment. Metabolomic and lipidomic analysis have not been done in pediatric rheumatic diseases such as JIA. Based on studies in rheumatoid arthritis and its “lipid paradox,” we decided to evaluate the synovial fluid of 3 patients with oligoarticular JIA naïve to treatment.

Methods: All patients had joint aspiration followed by intraarticular steroid injection. Lipids were extracted from each synovial fluid sample according to published protocol and analyzed by ultra-high performance liquid chromatography/tandem mass spectrometry (UHPLC-MS/MS) on a Thermo Vanquish UHPLC system coupled to a Thermo Q-Exactive Orbitrap mass spectrometer.

Lipids were identified and integrated using LipidMatch software. Peak areas were normalized using the appropriate internal standards based on lipid class or chromatographic retention time. Relative-quantitative data were processed by principal component analysis (PCA) and one-way analysis of variance (ANOVA) with Fisher’s LSD post-hoc test using MetaboAnalyst software, statistical significance was inferred at p < 0.05.

Results: There were 471 lipid molecules identified in these samples. Of these, 341 appear to be significantly different between the 3 patients (p-value < 0.05), using “Anova_PostHoc” sorted by p-value. The lipids found in the largest amount included acyl-carnitines, ceramics, triacylglycerols, and phospholipids. 

Conclusion: The biologic significance of these individual lipid molecules to JIA subtype and status is currently being analyzed, as are the metabolomic results.


Disclosure: M. Elder, None; L. Paim marques, None; A. Thatayatikom, None; J. Bowden, None; B. da SIlva, None; J. Aristizabal, None.

To cite this abstract in AMA style:

Elder M, Paim marques L, Thatayatikom A, Bowden J, da SIlva B, Aristizabal J. Lipidomic Profiles of Synovial Fluid from Patients with Oligoarticular Juvenile Idiopathic Arthritis Naïve to Treatment [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/lipidomic-profiles-of-synovial-fluid-from-patients-with-oligoarticular-juvenile-idiopathic-arthritis-naive-to-treatment/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lipidomic-profiles-of-synovial-fluid-from-patients-with-oligoarticular-juvenile-idiopathic-arthritis-naive-to-treatment/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology